<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>79</number>
    <updateDate>2023-09-20T14:08:33Z</updateDate>
    <updateDateIncludingText>2023-09-20T14:08:33Z</updateDateIncludingText>
    <originChamber>Senate</originChamber>
    <type>S</type>
    <introducedDate>2023-01-25</introducedDate>
    <congress>118</congress>
    <committees>
      <item>
        <systemCode>ssju00</systemCode>
        <name>Judiciary Committee</name>
        <chamber>Senate</chamber>
        <type>Standing</type>
        <activities>
          <item>
            <name>Reported by</name>
            <date>2023-03-01T21:12:25Z</date>
          </item>
          <item>
            <name>Markup by</name>
            <date>2023-02-09T14:52:34Z</date>
          </item>
          <item>
            <name>Referred to</name>
            <date>2023-01-25T20:42:22Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <relatedBills>
      <item>
        <title>Interagency Patent Coordination and Improvement Act of 2023</title>
        <congress>118</congress>
        <number>1717</number>
        <type>HR</type>
        <latestAction>
          <actionDate>2023-03-22</actionDate>
          <text>Referred to the House Committee on the Judiciary.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Identical bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
    </relatedBills>
    <actions>
      <item>
        <actionDate>2023-03-01</actionDate>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Placed on Senate Legislative Calendar under General Orders. Calendar No. 18.</text>
        <type>Calendars</type>
      </item>
      <item>
        <actionDate>2023-03-01</actionDate>
        <committees>
          <item>
            <systemCode>ssju00</systemCode>
            <name>Judiciary Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Committee on the Judiciary. Reported by Senator Durbin without amendment. Without written report.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2023-03-01</actionDate>
        <text>Committee on the Judiciary. Reported by Senator Durbin without amendment. Without written report.</text>
        <type>Committee</type>
        <actionCode>14000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>ssju00</systemCode>
            <name>Judiciary Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2023-02-09</actionDate>
        <committees>
          <item>
            <systemCode>ssju00</systemCode>
            <name>Judiciary Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Committee on the Judiciary. Ordered to be reported without amendment favorably.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2023-01-25</actionDate>
        <committees>
          <item>
            <systemCode>ssju00</systemCode>
            <name>Judiciary Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Read twice and referred to the Committee on the Judiciary.</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <actionDate>2023-01-25</actionDate>
        <text>Introduced in Senate</text>
        <type>IntroReferral</type>
        <actionCode>10000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>D000563</bioguideId>
        <fullName>Sen. Durbin, Richard J. [D-IL]</fullName>
        <firstName>Richard</firstName>
        <lastName>Durbin</lastName>
        <party>D</party>
        <state>IL</state>
        <middleName>J.</middleName>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>T000476</bioguideId>
        <fullName>Sen. Tillis, Thomas [R-NC]</fullName>
        <firstName>Thomas</firstName>
        <lastName>Tillis</lastName>
        <party>R</party>
        <state>NC</state>
        <middleName>Roland</middleName>
        <sponsorshipDate>2023-01-25</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>G000386</bioguideId>
        <fullName>Sen. Grassley, Chuck [R-IA]</fullName>
        <firstName>Chuck</firstName>
        <lastName>Grassley</lastName>
        <party>R</party>
        <state>IA</state>
        <sponsorshipDate>2023-01-25</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>C001088</bioguideId>
        <fullName>Sen. Coons, Christopher A. [D-DE]</fullName>
        <firstName>Christopher</firstName>
        <lastName>Coons</lastName>
        <party>D</party>
        <state>DE</state>
        <middleName>A.</middleName>
        <sponsorshipDate>2023-01-25</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>W000800</bioguideId>
        <fullName>Sen. Welch, Peter [D-VT]</fullName>
        <firstName>Peter</firstName>
        <lastName>Welch</lastName>
        <party>D</party>
        <state>VT</state>
        <sponsorshipDate>2023-02-07</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>F000062</bioguideId>
        <fullName>Sen. Feinstein, Dianne [D-CA]</fullName>
        <firstName>Dianne</firstName>
        <lastName>Feinstein</lastName>
        <party>D</party>
        <state>CA</state>
        <sponsorshipDate>2023-02-07</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
    </cosponsors>
    <cboCostEstimates>
      <item>
        <pubDate>2023-07-06T18:42:00Z</pubDate>
        <title>S. 79, Interagency Patent Coordination and Improvement Act of 2023</title>
        <url>https://www.cbo.gov/publication/59353</url>
        <description>As reported by the Senate Committee on the Judiciary on March 1, 2023</description>
      </item>
    </cboCostEstimates>
    <policyArea>
      <name>Commerce</name>
    </policyArea>
    <subjects>
      <legislativeSubjects>
        <item>
          <name>Administrative remedies</name>
        </item>
        <item>
          <name>Department of Commerce</name>
        </item>
        <item>
          <name>Drug safety, medical device, and laboratory regulation</name>
        </item>
        <item>
          <name>Food and Drug Administration (FDA)</name>
        </item>
        <item>
          <name>Intellectual property</name>
        </item>
        <item>
          <name>Intergovernmental relations</name>
        </item>
      </legislativeSubjects>
      <policyArea>
        <name>Commerce</name>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2023-01-25</actionDate>
        <actionDesc>Introduced in Senate</actionDesc>
        <updateDate>2023-03-24T13:56:45Z</updateDate>
        <text><![CDATA[ <p><b>Interagency Patent Coordination and Improvement Act of 2023 </b></p> <p>This bill establishes the Interagency Task Force on Patents to support coordination and communication between the U.S. Patent and Trademark Office (PTO) and the Food and Drug Administration (FDA) on activities relating to patents for human drugs and biological products. </p> <p>The task force's duties shall include sharing information about (1) the processes of each agency, including how each agency evaluates applications (e.g., patent applications at the PTO and new drug applications at the FDA); and (2) new approvals of patents, human drugs, biological products, and new technologies. The task force must also establish a process that requires (1) the PTO to request from the FDA information relating to certain patent applications to help patent examiners carry out their duties, (2) the FDA to provide such information to the PTO, and (3) the PTO to assist the FDA in its ministerial role of listing patents.</p>]]></text>
      </summary>
      <summary>
        <versionCode>25</versionCode>
        <actionDate>2023-03-01</actionDate>
        <actionDesc>Reported to Senate</actionDesc>
        <updateDate>2023-04-06T14:20:43Z</updateDate>
        <text><![CDATA[ <p><b>Interagency Patent Coordination and Improvement Act of 2023 </b></p> <p>This bill establishes the Interagency Task Force on Patents to support coordination and communication between the U.S. Patent and Trademark Office (PTO) and the Food and Drug Administration (FDA) on activities relating to patents for human drugs and biological products. </p> <p>The task force's duties shall include sharing information about (1) the processes of each agency, including how each agency evaluates applications (e.g., patent applications at the PTO and new drug applications at the FDA); and (2) new approvals of patents, human drugs, biological products, and new technologies. The task force must also establish a process that requires (1) the PTO to request from the FDA information relating to certain patent applications to help patent examiners carry out their duties, (2) the FDA to provide such information to the PTO, and (3) the PTO to assist the FDA in its ministerial role of listing patents.</p>]]></text>
      </summary>
    </summaries>
    <title>Interagency Patent Coordination and Improvement Act of 2023</title>
    <titles>
      <item>
        <titleType>Display Title</titleType>
        <title>Interagency Patent Coordination and Improvement Act of 2023</title>
      </item>
      <item>
        <titleType>Short Title(s) as Reported to Senate</titleType>
        <title>Interagency Patent Coordination and Improvement Act of 2023</title>
        <chamberCode>S</chamberCode>
        <chamberName>Senate</chamberName>
        <billTextVersionName>Reported to Senate</billTextVersionName>
        <billTextVersionCode>RS</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Title(s) as Introduced</titleType>
        <title>Interagency Patent Coordination and Improvement Act of 2023</title>
        <billTextVersionName>Introduced in Senate</billTextVersionName>
        <billTextVersionCode>IS</billTextVersionCode>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <title>A bill to amend title 35, United States Code, to establish an interagency task force between the United States Patent and Trademark Office and the Food and Drug Administration for purposes of sharing information and providing technical assistance with respect to patents, and for other purposes.</title>
        <billTextVersionName>Introduced in Senate</billTextVersionName>
        <billTextVersionCode>IS</billTextVersionCode>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Reported to Senate</type>
        <date>2023-03-01T05:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-118s79rs/xml/BILLS-118s79rs.xml</url>
          </item>
        </formats>
      </item>
      <item>
        <type>Introduced in Senate</type>
        <date>2023-01-25T05:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-118s79is/xml/BILLS-118s79is.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2023-03-01</actionDate>
      <text>Placed on Senate Legislative Calendar under General Orders. Calendar No. 18.</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
